Live oral attenuated rotavirus vaccine
Rotavirus vaccine
Brand names: Rotarix
Adult dose
Dose: Paediatric only: 1.5mL PO at 8 and 12 weeks
Route: PO
Frequency: x2 doses
Clinical pearls
- UK childhood immunisation: 8 + 12 weeks; complete by 24 weeks
- Spit-out doses not repeated
Contraindications
- Previous intussusception
- SCID
- Combined immunodeficiency
- Age >24 weeks 0 days at first dose
- Acute severe illness
Side effects
- Diarrhoea
- Vomiting
- Fever
- Intussusception (small risk — withhold if signs)
Interactions
- Immunosuppressives
- Live vaccines (no minimum interval needed)
Reference: BNF; UKHSA Green Book Ch.27b; https://bnf.nice.org.uk/drugs/rotavirus-vaccine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023